OC
BHVN icon

Oppenheimer & Co’s Biohaven BHVN Stock Holding History

Oppenheimer & Co’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$166K Sell
19,635
-1,114
-5% -$12.2K ﹤0.01% 1600
2025
Q4 		$234K Sell
20,749
-10,695
-34% -$132K ﹤0.01% 1371
2025
Q3 		$472K Buy
+31,444
New +$458K 0.01% 1194

Other funds holding BHVN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $173M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Oppenheimer & Co's BHVN Position: Q1 2026 in Review

Oppenheimer & Co reduced its Biohaven (BHVN) stake by 5.4% in Q1 2026, selling an estimated $12.2K and leaving 19,635 shares worth $166K. The position accounts for ﹤0.01% of the portfolio, ranked #1600.

Oppenheimer & Co first reported a position in BHVN in Q3 2025 and has held it in 3 quarters since. The position peaked at $472K in Q3 2025. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

  • Oppenheimer & Co held 19,635 shares of Biohaven worth $166K as of Q1 2026.
  • Oppenheimer & Co sold 1,114 Biohaven shares in Q1 2026, an estimated $12.2K.
  • Biohaven made up ﹤0.01% of Oppenheimer & Co's portfolio in Q1 2026, its #1600 holding.
  • Oppenheimer & Co first reported a position in Biohaven in Q3 2025 and has held it in 3 quarters since.
  • Oppenheimer & Co's Biohaven position peaked at $472K in Q3 2025.
  • 275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.